| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.6326U |
| P356 | DOI | 10.1073/PNAS.0601223103 |
| P932 | PMC publication ID | 1458877 |
| P698 | PubMed publication ID | 16606835 |
| P5875 | ResearchGate publication ID | 7172901 |
| P50 | author | Colin D Funk | Q56957754 |
| Barbara Uzonyi | Q55427920 | ||
| P2093 | author name string | Andreas J R Habenicht | |
| Michael Beer | |||
| Dörte Radke | |||
| Katharina Lötzer | |||
| Markus Hildner | |||
| Steffen Jahn | |||
| Rüdiger Vollandt | |||
| Jilly F Evans | |||
| Ellen Bretschneider | |||
| Cornelia Kramer | |||
| P2860 | cites work | Characterization of the human cysteinyl leukotriene CysLT1 receptor | Q22010199 |
| Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R | Q24673057 | ||
| International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors | Q28180458 | ||
| Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis | Q28205296 | ||
| MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
| Transcellular sulfidopeptide leukotriene biosynthetic capacity of vascular cells | Q69352974 | ||
| Leukotriene A4, and not leukotriene B4, is the main 5-lipoxygenase metabolite released by bovine leukocytes | Q71215398 | ||
| Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells | Q73686895 | ||
| The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin | Q73822798 | ||
| Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment | Q73886545 | ||
| Active tissue factor in blood? | Q80937513 | ||
| Tissue factor activity in whole blood | Q81157689 | ||
| Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 | ||
| Transduction of receptor signals by beta-arrestins | Q28246395 | ||
| Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells | Q28249984 | ||
| Role of tissue factor in hemostasis, thrombosis, and vascular development | Q28259220 | ||
| Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis | Q28284677 | ||
| Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress | Q28512203 | ||
| The ADAMTS metalloproteinases | Q29544428 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Thrombin signalling and protease-activated receptors | Q29619601 | ||
| Characterization of the human cysteinyl leukotriene 2 receptor | Q30305734 | ||
| Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation | Q30433441 | ||
| High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. | Q33939860 | ||
| Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation | Q34254403 | ||
| COX-2 and beyond: Approaches to prostaglandin inhibition in human disease | Q34282832 | ||
| Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure | Q34368064 | ||
| Leukotriene receptors: classification, gene expression, and signal transduction | Q34720495 | ||
| Cysteinyl leukotriene receptors | Q34995382 | ||
| Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses | Q35841909 | ||
| The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. | Q36017199 | ||
| Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia | Q36174464 | ||
| Leukotriene modifiers as potential therapeutics for cardiovascular disease | Q36205826 | ||
| The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis | Q36218949 | ||
| Protease-activated receptors in hemostasis, thrombosis and vascular biology | Q36230881 | ||
| Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis | Q36853612 | ||
| The combined role of P- and E-selectins in atherosclerosis | Q37387115 | ||
| Growth factor-responsive genes in fibroblasts. | Q37831984 | ||
| Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. | Q40493102 | ||
| Histamine induces nuclear factor of activated T cell-mediated transcription and cyclosporin A-sensitive interleukin-8 mRNA expression in human umbilical vein endothelial cells. | Q41020235 | ||
| Thrombin receptors activate G(o) proteins in endothelial cells to regulate intracellular calcium and cell shape changes. | Q42051351 | ||
| Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. | Q44484476 | ||
| The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. | Q45025551 | ||
| Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice | Q45029761 | ||
| PAR1 cleavage and signaling in response to activated protein C and thrombin. | Q46022355 | ||
| Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. | Q48230335 | ||
| Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. | Q52005840 | ||
| Calcium-independent calcineurin regulation. | Q55036788 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6326-31 | |
| P577 | publication date | 2006-04-18 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells | |
| P478 | volume | 103 |
| Q34084772 | Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression |
| Q37633331 | An update on the role of leukotrienes in asthma |
| Q46961500 | Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells |
| Q38681468 | Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy |
| Q35206683 | Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes. |
| Q39104480 | Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. |
| Q28582197 | CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes |
| Q90595284 | Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis |
| Q42876825 | Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT₂ and CysLT₁ receptors |
| Q34145036 | Differential Signaling Defects Associated with the M201V Polymorphism in the Cysteinyl Leukotriene Type 2 Receptor |
| Q40216264 | Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects |
| Q36970702 | Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? |
| Q37995534 | Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke |
| Q36482287 | Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury. |
| Q37208991 | Expanding roles for leukotrienes in airway inflammation |
| Q41919050 | Feedback regulation by Atf3 in the endothelin-1-responsive transcriptome of cardiomyocytes: Egr1 is a principal Atf3 target |
| Q46091192 | Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals |
| Q41442898 | Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor |
| Q28275552 | Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99 |
| Q36652544 | Leukotriene receptors in atherosclerosis |
| Q37145833 | Leukotriene signaling in atherosclerosis and ischemia |
| Q35106124 | Leukotrienes and airway inflammation |
| Q27025129 | Leukotrienes as modifiers of preclinical atherosclerosis? |
| Q99711250 | Leukotrienes in Tumor-Associated Inflammation |
| Q36462026 | Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations |
| Q33399367 | Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice |
| Q37794115 | Mast Cells in Allergic Asthma and Beyond |
| Q36819905 | Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation |
| Q36699060 | Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications. |
| Q35165708 | Modelling negative feedback networks for activating transcription factor 3 predicts a dominant role for miRNAs in immediate early gene regulation |
| Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
| Q43067613 | Novel mutations in leukotriene C4 synthase and risk of cardiovascular disease based on genotypes from 50,000 individuals |
| Q34168176 | RNA-seq reveals novel transcriptome of genes and their isoforms in human pulmonary microvascular endothelial cells treated with thrombin |
| Q33280659 | Regulatory network of inflammation downstream of proteinase-activated receptors |
| Q34414600 | Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury. |
| Q41432422 | Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases |
| Q53538229 | Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. |
| Q40042544 | Signaling by the cysteinyl-leukotriene receptor 2. Involvement in chemokine gene transcription |
| Q28487946 | The landscape of host transcriptional response programs commonly perturbed by bacterial pathogens: towards host-oriented broad-spectrum drug targets |
Search more.